The Autopsy / Case File · Overdose & Substance
The Data Nobody Runs
A drug-checking service can tell someone what's in their bag in minutes. The federal government's own mortality count takes six months to catch up.
There is no national agency whose job is to know, in real time, what's actually in the American drug supply. What exists instead is a scattered network of syringe service programs, university labs, and harm-reduction nonprofits running mass spectrometers and test strips on their own budgets, feeding a surveillance system that federal agencies lean on but don't operate. Here's how the fastest overdose-prevention data in the country gets made, and why it keeps almost losing its funding.
Join the discussion →
When someone dies of a drug overdose in the United States, the death eventually gets coded, filed, and folded into the CDC's official count. That count is the number news outlets cite, the number that shapes federal funding formulas, the number the country uses to ask whether the crisis is getting better or worse. It is also, by the CDC's own admission, a number that lags reality by months — long enough that a new adulterant can spread through a regional drug supply, kill people, and still not show up in the government's own numbers until well after the fact.
A Six-Month Blind Spot, By Design
The National Vital Statistics System, which produces the country's official overdose death counts, runs on death certificates — documents that have to be completed by a physician or medical examiner, coded by a state vital records office, and transmitted to the National Center for Health Statistics before a death is countable at all. Toxicology results alone, in cases that require them, can take weeks. The result is a reporting lag of roughly six months between when a fatal overdose happens and when it's reflected in CDC's provisional data, with fully finalized annual counts arriving later still.
That lag isn't a flaw anyone is trying to hide. CDC publishes the provisional numbers with the caveat attached, and adjusts for the undercount using statistical modeling once enough time has passed for the true rate to become clear. But a statistical correction, however sound, doesn't help a person deciding whether it's safe to use a specific bag from a specific supply tonight. For that, the six-month system is functionally useless. Something else has to fill the gap.
What A Test Strip Can Tell You In Ninety Seconds
The gap is filled, unevenly, by drug-checking services — syringe service programs, university research partnerships, and standalone harm-reduction nonprofits that take a sample of a person's actual drugs, run it through a fentanyl test strip or a portable spectrometer, and hand back a result before that person uses. It is, structurally, the opposite of the federal system: instead of a national count built retroactively from death certificates, it's a hyperlocal, real-time readout of what a specific supply actually contains, built one voluntary sample at a time.
A study led by researchers at Rhode Island Hospital, funded through the Bloomberg American Health Initiative at Johns Hopkins Bloomberg School of Public Health, tested this approach directly: more than 200 samples of police-confiscated street drugs were run through three portable technologies — a benchtop Fourier-transform infrared spectrometer, a handheld Raman spectrometer, and fentanyl test strips — to see which actually worked in the field. The test strips, the cheapest and simplest of the three by a wide margin, came out on top for detecting fentanyl itself.
The tradeoffs are real. Fentanyl test strips are cheap and fast but tell a user only whether fentanyl is present, not how much, and not what else might be mixed in. Spectrometers can identify a much broader range of substances but cost thousands of dollars, require some training to interpret, and can struggle with mixtures where one compound masks another. Laboratory-grade mass spectrometry catches almost everything but requires shipping a sample off-site and waiting for results — a turnaround measured in days, not the minutes a person standing outside a syringe service van actually has.
No test strip and no spectrometer can move faster than a six-month government lag needs it to. The problem drug-checking programs actually solve is a different one: getting a real answer to a real person before they use, not building a better national count after the fact.
A Legal Patchwork Built On Top Of A Data Patchwork
Even where the technology works, the law hasn't consistently caught up to it. For years, most states classified fentanyl test strips as drug paraphernalia — the same legal category as the syringes and pipes explicitly meant to be illegal to distribute — which meant a harm-reduction worker handing one out could, in some jurisdictions, be committing a crime. That changed only gradually: in 2021, CDC and the Substance Abuse and Mental Health Services Administration announced that federal harm-reduction grant money could finally be used to purchase fentanyl test strips, a policy shift that acknowledged what public health researchers had been arguing for years.
Ohio's 2022 update to its paraphernalia statute is a representative example of how narrow these fixes tend to be: Senate Bill 288 carved out an exception specifically for fentanyl test strips, and nothing else. A harm-reduction program that wants to hand out test strips for xylazine, benzodiazepines, or any of the other adulterants now circulating alongside fentanyl is often working in the same legal gray zone fentanyl strips occupied a few years ago — waiting on a state legislature to notice a specific product exists and write it a specific exemption, one substance at a time, while the drug supply itself keeps moving faster than that process does.
Who's Actually Running The System That Works
No single organization coordinates drug checking nationally. The closest thing to a coordinating body is the National Drug Early Warning System, a sentinel-site network originally built through a cooperative agreement between the National Institute on Drug Abuse and the University of Maryland's Center for Substance Abuse Research. NDEWS doesn't run drug-checking devices itself; it aggregates trend data from sentinel sites and community-based experts around the country and treats venue-based drug-checking results as one input among several, feeding a public health early-warning function that is explicitly meant to move faster than official mortality statistics.
The actual testing work happens downstream of that, inside individual syringe service programs and university partnerships that vary enormously by state and by budget. CDC's Overdose Data to Action initiative requires a subset of its funded state and local health department grantees to run drug-checking or paraphernalia-testing programs as one surveillance strategy among many, which means federal money does flow into this work — but through a grant condition attached to a broader initiative, not through an agency whose sole job is running a national drug-checking network. A 2024 implementation study of programs in Ohio and Indiana, published in Harm Reduction Journal, found individual syringe service programs cobbling together funding from university research grants, state opioid settlement dollars, and philanthropic sources like the Berthiaume Institute for Precision Health — a funding base that can vanish with a single grant cycle in a way NVSS's federal budget line never does.
That funding precarity is the structural problem underneath the technical one. Drug-checking services have already solved the speed problem the federal mortality-counting system can't solve by design — a test strip doesn't need six months to tell someone what's in their bag. What they haven't solved, and can't solve on their own, is durability. A syringe service program running on a two-year settlement grant can build exactly the real-time surveillance capacity the country's official numbers lack, and then lose it the moment that grant isn't renewed — while the six-month lag in the federal count, underfunded as its own surveillance infrastructure sometimes is, keeps running every year on autopilot because it's written into a permanent statistical system. The fastest data in the overdose crisis is also the most fragile.
And Then You're Dead
A test strip works in ninety seconds. A federal mortality count takes six months. The country built the slow system to last and the fast one to depend on whichever grant cycle happens to still be funded this year — and the gap between those two timelines is measured in overdoses nobody saw coming until the paperwork caught up.
That's it. That's the whole thing.
Sources
- Approximate six-month reporting lag between a fatal overdose and its appearance in provisional National Vital Statistics System counts, and CDC's statistical adjustment methodology for the undercount — CDC NCHS, "Vital Statistics Rapid Release — Provisional Drug Overdose Data" and "Clarifying CDC's Efforts to Quantify Overdose Deaths," PMC
- CDC Overdose Data to Action requirement that a subset of funded state and local jurisdictions test drug products and paraphernalia to track emerging threats in illicit drug markets — CDC, "Overdose Data to Action: Surveillance Strategies"
- Rhode Island Hospital/Johns Hopkins Bloomberg American Health Initiative field study of 200+ police-confiscated drug samples across three portable drug-checking technologies (FTIR, Raman, fentanyl test strips), and the resulting sensitivity/specificity findings — Brown University Health, "Study Led by R.I. Hospital Researcher: Portable Devices Can Detect Fentanyl in Street Drugs", underlying study also indexed at PubMed, "An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples"
- Implementation study of low-barrier drug-checking methods in Ohio and Indiana syringe service programs, including LC-MS/MS detection limits for 22 common drugs, funding sources, and the 2021 CDC/SAMHSA policy change permitting federal harm-reduction funds to purchase fentanyl test strips — Moon et al., "Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA," Harm Reduction Journal, 2024
- Pre-2021 state paraphernalia law landscape for fentanyl test strips (30 states prohibiting possession, 33 prohibiting distribution) and Ohio Senate Bill 288's narrow fentanyl-strip-only exemption — cited within the Moon et al. 2024 Harm Reduction Journal implementation study above
- National Drug Early Warning System's founding, funding, and mission as a sentinel-site early-warning network incorporating drug-checking data — University of Maryland Center for Substance Abuse Research (CESAR), "National Drug Early Warning System (NDEWS)" and National Institute on Drug Abuse, "National Drug Early Warning System (NDEWS)"
Photo: "Portable RAMAN Laser Spectrometer" by Dean Calma/IAEA Imagebank, via Wikimedia Commons (CC BY 2.0), cropped from the original.
Comments
Loading…